Skip to main content
OpenTrials
Completed

NCT Number: NCT07635069

Cognitive Effectiveness of Somatotherapy and Occupational Therapy in Post-Stroke Patients.

The objective of this study was to evaluate the cognitive effectiveness of somatotherapy and occupational therapy in post-stroke patients by measuring their cognitive potential outcomes using the Montreal Cognitive Assessment (MoCA) test.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Swat Medical Complex

Swat, Khyber Pakhtunkhwa, 26000, Pakistan

About this study

Stroke is a leading cause of death and long-term disability worldwide. Cognitive impairment is a common and disabling consequence of stroke that significantly affects patients' functional independence and quality of life.

Somatotherapy (targeted physical and sensorimotor therapy) and occupational therapy (focused on activities of daily living) are frequently used rehabilitation approaches, but their combined effect on cognitive recovery in post-stroke patients requires further evaluation.

This was a single-center, retrospective observational study conducted at the department of physical therapy, King Hospital, Swat, Pakistan. Medical records of 50 post-stroke patients (30 males, 20 females; age range 30-60 years) who received inpatient rehabilitation between 2018 and 2019 were analyzed.

Participants

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 30 years and above
  • Diagnosed with ischemic or hemorrhagic stroke (first-ever or recurrent)
  • Referred to physical therapy department for cognitive rehabilitation
  • Received somatotherapy and occupational therapy during hospitalization
  • Able to undergo MoCA (Montreal Cognitive Assessment) testing

Exclusion criteria

  • Severe speech impairment (aphasia) that prevents reliable cognitive testing
  • Significant visual impairment that interferes with MoCA testing
  • Significant hearing impairment that interferes with MoCA testing
  • Inability to participate in therapy sessions.

Treatment and study plan

Somatotherapy and Occupational Therapy

Other

Combined somatotherapy and occupational therapy delivered during inpatient hospitalization.

Somatotherapy consisted of structured sensorimotor and physical therapy targeting body awareness, movement, balance, and coordination. Occupational therapy focused on patient-specific, task-oriented training in activities of daily living (ADLs) such as self-care, functional mobility, and cognitive integration during daily tasks.

Patients received 35-minute sessions, 5 days per week for 4 consecutive weeks. Therapy was customized according to individual patient needs and used equipment including adjustable tables, chairs, wheelchairs, and assistive aids (splints, glasses, etc.).

Primary outcomes

  1. Montreal Cognitive Assessment

    Time frame: 4 weeks

    To detect mild cognitive impairment and assess for early stages of dementia. This scale utilizes a minimum value of 0 and a maximum value of 30, where higher scores mean a better outcome (a score of 26 or above is considered normal, while a score of 22 suggests mild cognitive impairment.

Sponsors and collaborators

Lead sponsor

Iqra National University

Other

Registry information

Official study title

The Cognitive Effectiveness of Somatotherapy & Occupational Therapy in Post-Stroke Patients

Acronym: CESTO

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jun 9, 2026
Registry last updated
Jun 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.